Date | Company Name | Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|---|
Dec 21, 2021 | Ambys Medicines | Series A | — | Biotechnology | Yes |
Aug 8, 2018 | Ambys Medicines | Series A | — | Biotechnology | Yes |
Nov 12, 2014 | Blueprint Medicines | Series C | — | Bioinformatics | — |
Apr 23, 2014 | Kala Pharmaceuticals | Series B | — | Biotechnology | — |
Jan 7, 2014 | Blueprint Medicines | Series B | — | Bioinformatics | — |
Feb 28, 2013 | Kala Pharmaceuticals | Series A | — | Biotechnology | — |
Jul 25, 2012 | Bluebird Bio | Series D | — | Biotechnology | — |
Mar 14, 2012 | Kala Pharmaceuticals | Private Equity(PE) | — | Biotechnology | — |
Apr 20, 2011 | Bluebird Bio | Series C | — | Biotechnology | — |
Apr 11, 2011 | Blueprint Medicines | Series A | — | Bioinformatics | Yes |
Mar 12, 2010 | Bluebird Bio | Series B | — | Biotechnology | Yes |